Most Popular
-
1
Dongduk Women’s University halts coeducation talks
-
2
Defense ministry denies special treatment for BTS’ V amid phone use allegations
-
3
OpenAI in talks with Samsung to power AI features, report says
-
4
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
-
5
Two jailed for forcing disabled teens into prostitution
-
6
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
-
7
S. Korea not to attend Sado mine memorial: foreign ministry
-
8
South Korean military plans to launch new division for future warfare
-
9
Kia EV9 GT marks world debut at LA Motor Show
-
10
Gold bars and cash bundles; authorities confiscate millions from tax dodgers
3 Korean brokerages buy Novo Nordisk’s US HQ building
By Korea HeraldPublished : June 29, 2016 - 14:52
[THE INVESTOR] Three Korean securities firms have decided to jointly acquire a pharmaceutical company’s headquarters building in the US for 350 billion won (US$301 million) as a part of their real estate investment, sources said on June 29.
Mirae Asset Daewoo, Hana Financial Investment and HMC Investment & Securities will buy the building used by Novo Nordisk, Danish pharmaceutical company, which signed a 15-year lease on the property in 2011.
Located in New Jersey, the 68,000 square-meter building is expected to generate annual return of 7 percent.
By Park Han-na (hnpark@heraldcorp.com)
Mirae Asset Daewoo, Hana Financial Investment and HMC Investment & Securities will buy the building used by Novo Nordisk, Danish pharmaceutical company, which signed a 15-year lease on the property in 2011.
Located in New Jersey, the 68,000 square-meter building is expected to generate annual return of 7 percent.
By Park Han-na (hnpark@heraldcorp.com)
-
Articles by Korea Herald
